vs
Side-by-side financial comparison of BEASLEY BROADCAST GROUP INC (BBGI) and BillionToOne, Inc. (BLLN). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $53.1M, roughly 1.6× BEASLEY BROADCAST GROUP INC). BillionToOne, Inc. runs the higher net margin — 6.8% vs -358.4%, a 365.3% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -21.2%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-4.4M).
Beasley Broadcast Group, Inc., based in Naples, Florida, is an owner/operator of radio stations in the United States. As of September 2025, the company owns 54 stations under the Beasley Media Group name.
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
BBGI vs BLLN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.1M | $83.5M |
| Net Profit | $-190.1M | $5.7M |
| Gross Margin | — | 69.9% |
| Operating Margin | -433.6% | 11.5% |
| Net Margin | -358.4% | 6.8% |
| Revenue YoY | -21.2% | 117.4% |
| Net Profit YoY | -9136.7% | 138.3% |
| EPS (diluted) | $-105.71 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $53.1M | — | ||
| Q3 25 | $51.0M | $83.5M | ||
| Q2 25 | $53.0M | — | ||
| Q1 25 | $48.9M | — | ||
| Q4 24 | $67.3M | $45.1M | ||
| Q3 24 | $58.2M | $38.4M | ||
| Q2 24 | $60.4M | — | ||
| Q1 24 | $54.4M | — |
| Q4 25 | $-190.1M | — | ||
| Q3 25 | $-3.6M | $5.7M | ||
| Q2 25 | $-154.2K | — | ||
| Q1 25 | $-2.7M | — | ||
| Q4 24 | $-2.1M | $-11.5M | ||
| Q3 24 | $-3.6M | $-14.9M | ||
| Q2 24 | $-276.0K | — | ||
| Q1 24 | $8.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 69.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 52.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -433.6% | — | ||
| Q3 25 | -1.1% | 11.5% | ||
| Q2 25 | 5.5% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 11.3% | 17.0% | ||
| Q3 24 | 2.1% | -32.9% | ||
| Q2 24 | 8.9% | — | ||
| Q1 24 | -2.0% | — |
| Q4 25 | -358.4% | — | ||
| Q3 25 | -7.0% | 6.8% | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | -5.5% | — | ||
| Q4 24 | -3.1% | -25.5% | ||
| Q3 24 | -6.1% | -38.8% | ||
| Q2 24 | -0.5% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | $-105.71 | — | ||
| Q3 25 | $-1.97 | $0.10 | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-1.50 | — | ||
| Q4 24 | $-1.23 | $-1.13 | ||
| Q3 24 | $-2.33 | $-1.47 | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.9M | $195.2M |
| Total DebtLower is stronger | — | $55.0M |
| Stockholders' EquityBook value | $-49.3M | $-239.5M |
| Total Assets | $299.3M | $327.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | — | ||
| Q3 25 | $14.3M | $195.2M | ||
| Q2 25 | $13.7M | — | ||
| Q1 25 | $12.2M | — | ||
| Q4 24 | $13.8M | $191.5M | ||
| Q3 24 | $27.8M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $27.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $247.1M | $51.5M | ||
| Q3 24 | $265.2M | — | ||
| Q2 24 | $264.9M | — | ||
| Q1 24 | $264.5M | — |
| Q4 25 | $-49.3M | — | ||
| Q3 25 | $141.0M | $-239.5M | ||
| Q2 25 | $144.5M | — | ||
| Q1 25 | $144.6M | — | ||
| Q4 24 | $147.2M | $-251.7M | ||
| Q3 24 | $145.8M | $-242.9M | ||
| Q2 24 | $149.1M | — | ||
| Q1 24 | $149.1M | — |
| Q4 25 | $299.3M | — | ||
| Q3 25 | $534.6M | $327.5M | ||
| Q2 25 | $548.0M | — | ||
| Q1 25 | $539.3M | — | ||
| Q4 24 | $549.2M | $302.1M | ||
| Q3 24 | $571.5M | — | ||
| Q2 24 | $573.2M | — | ||
| Q1 24 | $566.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.68× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | 1.78× | — | ||
| Q1 24 | 1.77× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.2M | $13.8M |
| Free Cash FlowOCF − Capex | $-4.4M | $6.5M |
| FCF MarginFCF / Revenue | -8.3% | 7.7% |
| Capex IntensityCapex / Revenue | 2.3% | 8.8% |
| Cash ConversionOCF / Net Profit | — | 2.42× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $-4.9M | $13.8M | ||
| Q2 25 | $3.1M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-4.8M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $-4.0M | — |
| Q4 25 | $-4.4M | — | ||
| Q3 25 | $-7.1M | $6.5M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-5.4M | — | ||
| Q2 24 | $5.6M | — | ||
| Q1 24 | $-5.0M | — |
| Q4 25 | -8.3% | — | ||
| Q3 25 | -14.0% | 7.7% | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | -8.7% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -9.3% | — | ||
| Q2 24 | 9.2% | — | ||
| Q1 24 | -9.2% | — |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 4.4% | 8.8% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -506.51× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBGI
| Audio Advertising | $40.5M | 76% |
| Digital Advertising | $12.6M | 24% |
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
